Biotech Analysis Central

• 

  10/3/2024

  **Novavax Struggles with Unstable Revenue Growth**

• 

  10/3/2024

  **MannKind Expands in Pulmonary Market with DPI Strength**

• 

  10/2/2024

  **Melanoma Data Release: Proof-of-Concept for Radiotherapy**

• 10/2/2024

  **Avidity Biosciences: Compelling Oligonucleotide Program Worth Watching**

• 10/2/2024

  **AbbVie: $200 Peak Rating Downgraded**

• 10/2/2024

  **FDA Approves Phase 1 Trials for AI-Discovered Cancer Treatment**

• 10/1/2024

  **IBD Targeting: Unlocking Differentiation with Advanced Half-Life Tech**

• 9/30/2024

  **CVS Health Under Pressure from Glenview’s Activism**

• 9/30/2024

  **Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Transcript**

• 9/30/2024

  **Qualcomm’s Pursuit of Intel Threatens TSMC**